Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.

PLoS Genetics
Daniel I ChasmanPaul M Ridker

Abstract

While conventional LDL-C, HDL-C, and triglyceride measurements reflect aggregate properties of plasma lipoprotein fractions, NMR-based measurements more accurately reflect lipoprotein particle concentrations according to class (LDL, HDL, and VLDL) and particle size (small, medium, and large). The concentrations of these lipoprotein sub-fractions may be related to risk of cardiovascular disease and related metabolic disorders. We performed a genome-wide association study of 17 lipoprotein measures determined by NMR together with LDL-C, HDL-C, triglycerides, ApoA1, and ApoB in 17,296 women from the Women's Genome Health Study (WGHS). Among 36 loci with genome-wide significance (P<5x10(-8)) in primary and secondary analysis, ten (PCCB/STAG1 (3q22.3), GMPR/MYLIP (6p22.3), BTNL2 (6p21.32), KLF14 (7q32.2), 8p23.1, JMJD1C (10q21.3), SBF2 (11p15.4), 12q23.2, CCDC92/DNAH10/ZNF664 (12q24.31.B), and WIPI1 (17q24.2)) have not been reported in prior genome-wide association studies for plasma lipid concentration. Associations with mean lipoprotein particle size but not cholesterol content were found for LDL at four loci (7q11.23, LPL (8p21.3), 12q24.31.B, and LIPG (18q21.1)) and for HDL at one locus (GCKR (2p23.3)). In addition, genetic dete...Continue Reading

References

Oct 7, 1988·JAMA : the Journal of the American Medical Association·M A AustinR M Krauss
Sep 20, 1969·Lancet·M F OliverJ A Heady
Sep 20, 1969·Lancet·M J LangmanD R Ryrie
May 24, 1996·The Journal of Biological Chemistry·R J DalyR L Sutherland
Sep 18, 1996·JAMA : the Journal of the American Medical Association·M J StampferC H Hennekens
Jul 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John D Storey, Robert Tibshirani
Apr 24, 2004·Science·Gilean A T McVeanPeter Donnelly
Feb 18, 2005·Nature Reviews. Genetics·Joel N Hirschhorn, Mark J Daly
Mar 1, 2005·Nature Genetics·Ruta ValentonyteStefan Schreiber
Oct 26, 2005·Molecular Cell·Rafael S DepetrisStevan R Hubbard
Nov 18, 2006·Clinics in Laboratory Medicine·Elias J JeyarajahJames D Otvos
Nov 30, 2006·European Journal of Human Genetics : EJHG·Simona BarleraUNKNOWN PROCARDIS Consortium
Oct 19, 2007·Nature·UNKNOWN International HapMap ConsortiumJohn Stewart
Nov 3, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Dov ShiffmanBruce M Psaty
Jan 15, 2008·Nature Genetics·Cristen J WillerGonçalo R Abecasis
Jan 15, 2008·Nature Genetics·Jaspal S KoonerJohn F Thompson
Feb 12, 2008·Lancet·Manjinder S SandhuVincent Mooser
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Nov 22, 2008·Stroke; a Journal of Cerebral Circulation·May M LukeBruce M Psaty
Dec 9, 2008·Nature Genetics·Sekar KathiresanL Adrienne Cupples
Dec 9, 2008·Nature Genetics·Yurii S AulchenkoUNKNOWN ENGAGE Consortium

❮ Previous
Next ❯

Citations

Jul 6, 2014·PloS One·Gagandeep Kaur WaliaShah Ebrahim
Sep 24, 2015·Current Cardiovascular Risk Reports·Harvey J Murff, Todd L Edwards
Apr 23, 2010·The American Journal of Clinical Nutrition·V Saroja VorugantiAnthony G Comuzzie
Apr 28, 2010·Journal of Lipid Research·Daphna Weissglas-Volkov, Päivi Pajukanta
Feb 10, 2011·Circulation. Cardiovascular Genetics·Andrew C EdmondsonDaniel J Rader
Mar 30, 2011·Journal of Lipid Research·Magalie S LeducRon Korstanje
Mar 30, 2011·Hypertension·Andrew D JohnsonUNKNOWN Women's Genome Health Study
May 11, 2011·Cardiovascular Diabetology·Claudia Gragnoli
Jul 19, 2011·The Journal of Clinical Investigation·Daphna Weissglas-VolkovPäivi Pajukanta
Aug 24, 2011·World Journal of Cardiology·Panniyammakal JeemonSandosh Padmanabhan
Mar 16, 2012·Current Opinion in Lipidology·Cristen J Willer, Karen L Mohlke
Oct 30, 2012·Journal of Lipid Research·Debapriya BasuWeijun Jin
Oct 8, 2013·Nature Genetics·Cristen J WillerUNKNOWN Global Lipids Genetics Consortium
Nov 8, 2012·International Journal of Vascular Medicine·Hanrui ZhangMuredach P Reilly
Sep 26, 2013·Journal of Nutritional Science and Vitaminology·Yasuko SoneYoko Fujiwara
Jul 10, 2010·Current Opinion in Lipidology·Mohammad Mahdi MotazackerJan Albert Kuivenhoven
Dec 24, 2010·Current Opinion in Lipidology·Philippa J TalmudSteve E Humphries
Apr 29, 2010·Current Atherosclerosis Reports·Anders Mälarstig, Anders Hamsten
Jun 30, 2012·Lipids in Health and Disease·Paulo C J L SantosAlexandre C Pereira
Dec 25, 2012·Human Genetics·Alexis C Frazier-WoodDonna K Arnett
Jan 5, 2011·Critical Care Medicine·Anne Claire Lukaszewicz, Didier Payen

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
hormone replacement therapy
genotyping
PROCARDIS
chips
PCR

Software Mentioned

BeadStudio
PLINK
R
PROCARDIS
package QVALUE
EIGENSTRAT

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.